2C-T-7 Fast Facts, National Drug Intelligence Center, November 2004. This brochure answers common questions asked about 2C-T-7, a synthetic drug that produces hallucinogenic effects. It includes a description of the drug, describes the risks of abuse, and presents a profile of the typical abuser.
PDF / HTML

A

Alcohol and other drug treatment services in Australia 2006-07: findings from the National Minimum Data Set, Australian Institute of Health and Welfare, 2008. This report provides a statistical overview of substance abuse treatment agencies and client profiles in Australia.
PDF

Alucin�genos Y Drogas Disociativas, National Institute on Drug Abuse, July 2003. This report provides information on hallucinogens and dissociative drugs in Spanish.
HTML

D

The DASIS Report: Characteristics of Primary Phencyclidine (PCP) Admissions: 2001, Substance Abuse and Mental Health Services Administration, May 2004. This report examines primary PCP admissions and compares their characteristics with those of all other admissions reported to the Treatment Episode Data Set in 2001.
PDF / HTML

The DASIS Report: Trends in Admissions for PCP: 1993-2003, Substance Abuse and Mental Health Services Administration, October 2005. This resource provides data on trends in admissions to treatment for PCP abuse.
Summary / PDF / HTML

The DAWN Report: Trends in PCP-Related Emergency Department Visits, Substance Abuse and Mental Health Services Administration, January 2004. This fact sheet examines trends in PCP-related visits to hospital emergency departments nationally and in 21 metropolitan areas.
PDF

Drug Abuse and Addiction Research: 25 Years of Discovery to Advance the Health of the Public, National Institute on Drug Abuse, September 1999. An overview of drug use in the U.S., including data sources, information on specific drugs, and current research to treat drug addiction.
HTML

Drugs and Human Performance Fact Sheets, National Highway Traffic Safety Administration, B. Logan and J. Couper, April 2004. This collection of fact sheets represent the conclusions of a panel of international experts on drug-impaired driving and include the state of current scientific knowledge in the area of drugs and human performance for 16 drugs.
PDF / HTML

Drugs of Abuse: 2005 Edition, Drug Enforcement Administration, 2005. This report provides an overview of commonly abused legal and illegal drugs and their scheduling.
PDF / HTML

E

Exploring the Drugs-Crime Connection within the Electronic Dance Music and Hip-Hop Nightclub Scenes, NIJ-Sponsored, 2007. This study examined how the cultural ethos, behavioral norms, activities, and individual and group identities (subcultural features) inherent in the electronic dance music (EDM) and hip hop/rap (HH) nightclubs in Philadelphia, PA, impacted the relationship between alcohol/drugs and crime, with additional attention to victimization.
PDF

F

Foxy Fast Facts, National Drug Intelligence Center, September 2003. This brochure provides information on, a synthetic drug with the chemical name 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT).
PDF / HTML

Fry Fast Facts, National Drug Intelligence Center, November 2004. This brochure answers common questions asked about Fry, which is a street term for marijuana or tobacco cigarettes that are dipped in PCP (phencyclidine) and/or embalming fluid, and then dried.
PDF / HTML

H

Hallucinogens and Dissociative Drugs: Research Report, National Institute on Drug Abuse, March 2001. An overview of drugs that distort the way a user perceives time, motion, colors, sounds, and self.
PDF / HTML

Hallucinogens Facts & Figures, Office of National Drug Control Policy, September 2008. This online resource provides information and data on substances such as LSD, PCP, psilocybin mushrooms, mescaline, DMT, AMT, Foxy, and DXM with links to source materials.
HTML

I

InfoFacts: LSD, National Institute on Drug Abuse, June 2007. This resource provides information on the use and effects of lysergic acid diethylamide (LSD).
PDF / HTML

InfoFacts: PCP (Phencyclidine), National Institute on Drug Abuse, May 2006. This resource provides information on the use and health hazards associated with PCP.
PDF / HTML

K

Ketamine Intelligence Bulletin, National Drug Intelligence Center, July 2004. This bulletin discusses the trafficking and abuse of ketamine hydrochloride. It presents background information, smuggling from Mexico, abuse, effects, and its use in drug-facilitated sexual assault.
PDF / HTML

L

LSD Fast Facts, National Drug Intelligence Center, May 2003. This fact sheet provides general information on LSD.
PDF / HTML

M

Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2007, National Institute on Drug Abuse, 2008. This report presents trends in the use of licit and illicit drugs, as well as trends in the levels of perceived risk and personal disapproval associated with each drug.
PDF

Monitoring the Future National Survey Results on Drug Use, 1975-2007. Volume I: Secondary School Students, National Institute on Drug Abuse, 2008. This report provides data on the prevalence and frequency of drug use among American secondary school students as well as historical trends in use by students in this population.
PDF

Monitoring the Future National Survey Results on Drug Use, 1975-2007. Volume II: College Students and Adults Ages 19-45, National Institute on Drug Abuse, 2008. This report provides findings on the substance use and related behaviors of several segments of the adult population. It also contains findings on attitudes and beliefs about drugs, as well as on several particularly salient dimensions of their social environments.
PDF

N

National Forensic Laboratory Information System (NFLIS) 2007 Annual Report, Drug Enforcement Administration, June 2008. This report presents the results of drug cases analyzed by forensic laboratories in 2007 from the NFLIS.
PDF

The New DAWN Report: Emergency Department Visits Involving Dextromethorphan, Substance Abuse and Mental Health Services Administration, November 2006. This issue of The DAWN Report examines the characteristics of emergency department visits that involve dextromethorphan (DXM) and products containing DXM.
Summary / PDF / HTML

The NHSDA Report: Racial and Ethnic Differences in Youth Hallucinogen Use, Substance Abuse and Mental Health Services Administration, August 2003. This fact sheet provides data on the use of hallucinogens including LSD, PCP, Ecstasy, peyote, mescaline, and mushrooms.
PDF / HTML

The NSDUH Report: Patterns of Hallucinogen Use and Initiation: 2004 and 2005, Substance Abuse and Mental Health Services Administration, July 2007. This report examines patterns in the use of hallucinogens among persons aged 12 or older using 2004 and 2005 National Survey on Drug Use and Health (NSDUH) data.
Summary / PDF / HTML

The NSDUH Report: Use of Specific Hallucinogens: 2006, Substance Abuse and Mental Health Services Administration, February 2008. This report examines the prevalence and patterns of the use of various hallucinogenic drugs among persons aged 12 or older, based on 2006 National Survey on Drug Use and Health (NSDUH) data.
PDF / HTML

O

The OAS Report: A Day in the Life of American Adolescents: Substance Use Facts, Substance Abuse and Mental Health Services Administration, October 2007. This report presents facts about adolescent substance use, including initiation, and receipt of treatment for substance use "on an average day."
Summary / PDF / HTML

P

Patterns of Club Drug Use in the U.S., 2004, The Gulf Coast Addiction Technology Transfer Center, J. Maxwell, February 2004. This report provides information on the trends in ecstasy, GHB, ketamine, LSD, methamphetamine, and Rohypnol use.
PDF

PCP Fast Facts, National Drug Intelligence Center, May 2003. This brochure provides a brief overview of PCP and its effects.
PDF / HTML

PCP Tablets Sold as MDMA - Information Bulletin, National Drug Intelligence Center, April 2001. Informs the law enforcement and treatment communities of the nontraditional distribution of the hallucinogen PCP.
PDF / HTML